Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
18 Nov 2024 //
REUTERS
Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US
20 Jun 2024 //
FDA
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
20 Jun 2024 //
ACCESSWIRE
Norwich`s Generic Rifaximin Receives Approval in the U.S.
02 Jun 2023 //
FDA
Norwich`s Generic Lisdexamfetamine Dimesylate Receives Approval in the U.S.
19 Jan 2023 //
FDA